All ICNA Members are requested to "Register to Vote" for the upcoming Board Elections by following this link . Members are also requested to kindly complete the accompanying survey. Registration will remain open until 22 May 2022. The elections will take place from 23 May - 5 June 2022.
Inborn errors of metabolism (IEM) are individually rare but collectively they form a major group of treatable disorders in children. Affected children manifest with neurological and psychiatric symptoms that overlap more common conditions, and delayed diagnosis is not uncommon. Enhancing knowledge and understanding of these conditions will help neurologists establish early diagnosis. Unravelling the complexity of treatable neurometabolic disorders will enhance knowledge and impact outcomes through appropriate multidisciplinary management. This symposium will focus on the approach and management of patients with treatable neurometabolic disorders, IEM associated with hyperammonemia, pediatric neurotransmitter disorders, cerebral creatine deficiency syndromes and treatable IEMs associated epilepsies.
- Understand key metabolic pathways involved in the biosynthesis of essential neurotransmitters, the clinical presentations and the role of the laboratory in diagnosis of primary defects in neurotransmitter metabolism.
- Identify biochemical abnormalities and the clinical consequences in primary hyperammonemic disorders, their diagnoses and management.
- Identify the clinical phenotypes, diagnose various subtypes and optimize the management of inherited cerebral creatine deficiency syndromes.
- Identify the phenotype and diagnose treatable metabolic causes of epilepsy in children and adolescents.
- Timely recognition, utilization of appropriate biochemical and genetics testing to establish early diagnosis and improve outcomes in the four groups of metabolic disorders discussed through appropriate therapeutic interventions.
- Enhancing collaboration and establishing networks in the global pediatric neurology community dedicated to improve the outcomes of children affected by neurometabolic disorders. Organizer: Asuri N. Prasad, MBBS, MD, FRCPC, FRCPEdin, FAES; Schulich School of Medicine and Dentistry Western University, London, Ontario, Canada
Primary Disorders of Neurotransmitter Metabolism: Challenges in Diagnosis & Management Asuri N. Prasad, MBBS, MD, FRCPC, FRCPEdin, FAES
Primary Hyperammonemic Disorders: Neurological Implications, Current Diagnosis and Management Strategies Bindu Parayil Sankaran MD, DM, FRACP, PhD; Children Hospital at Westmead NSW, Sydney, Australia
Epilepsies Associated with IEM Annapurna Poduri, MD, MPH; Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Cerebral Creatine Deficiency Syndromes – An Underdiagnosed Entity: Clinical Aspects and Management Sangeetha Yoganathan, MD, DNB, DM; Christian Medical College, Tamil Nadu, India